Elective treatment of the neck for second primary tumors of the head and neck

Eur Arch Otorhinolaryngol. 2014 May;271(5):1187-90. doi: 10.1007/s00405-013-2623-9. Epub 2013 Jul 6.

Abstract

The aim of this study was to define the role of elective neck dissection in patients with a second N0 head and neck squamous cell carcinoma (HNSCC). We carried out a retrospective study in 74 patients with a second N0 HNSCC treated with an elective neck dissection. Thirteen patients (17.6%) had occult neck node metastases. The risk of occult neck nodes was low for patients with a second glottic tumor (0%), and for patients with non-glottic T1-T2 tumors who had received previous radiotherapy in the neck (5.3%). Patients with non-glottic locally advanced tumors (T3-T4) and non-glottic T1-T2 tumors who had not received previous radiotherapy in the neck had a risk of occult neck nodes of 28.1 and 33.3%, respectively. Elective neck dissection could be omitted in patients with glottic tumors and in patients with an early tumor (T1-T2) who had received previous radiotherapy in the neck.

MeSH terms

  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / radiotherapy
  • Carcinoma, Squamous Cell / surgery*
  • Combined Modality Therapy
  • Elective Surgical Procedures*
  • Humans
  • Kaplan-Meier Estimate
  • Lymphatic Metastasis / pathology
  • Neck Dissection*
  • Neoplasm Staging
  • Neoplasms, Second Primary / mortality
  • Neoplasms, Second Primary / pathology
  • Neoplasms, Second Primary / surgery*
  • Otorhinolaryngologic Neoplasms / mortality
  • Otorhinolaryngologic Neoplasms / pathology
  • Otorhinolaryngologic Neoplasms / radiotherapy
  • Otorhinolaryngologic Neoplasms / surgery*
  • Prognosis
  • Radiotherapy, Adjuvant
  • Reoperation
  • Retrospective Studies